Biogen Inc.
BIIB
$199.36
$1.410.71%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 32.85% | -118.34% | 20.08% | 8.77% | -38.87% |
| Total Depreciation and Amortization | 11.57% | 8.80% | 10.61% | 22.28% | 24.20% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 47.55% | 66.48% | 229.20% | 68.85% | -29.83% |
| Change in Net Operating Assets | 61.65% | -484.10% | -25.49% | -318.66% | -45.82% |
| Cash from Operations | 148.94% | -32.72% | 36.01% | -74.29% | -53.13% |
| Capital Expenditure | -38.01% | -11.70% | -32.00% | 20.60% | 19.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,451.96% | -5,838.16% | 115.57% | -106.08% | 49.25% |
| Cash from Investing | -342.92% | -6,522.04% | 97.03% | -112.22% | 28.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -600.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -90.43% | 1,710.13% | -1,868.18% | 2.08% | 41.92% |
| Cash from Financing | -90.43% | -1,834.18% | -1,872.73% | 95.23% | 94.77% |
| Foreign Exchange rate Adjustments | -152.48% | 103.36% | -107.55% | 642.06% | 248.48% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 67.58% | -226.41% | 626.47% | -80.77% | 811.43% |